Article

Differences in Clinical Characteristics, Results and Management of Patients Referred for Pharmacologic Cardiac Stress SPECT Depending on the Protocol Used

Register or Login to View PDF Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.

  • Views: 298

  • Likes: 0

  • Downloads: 4

Average (ratings)
No ratings
Your rating

Keywords

Radionuclide imaging, Stress, Vasodilator agents, Ischemia, Prognosis,

Received:

Accepted:

DOI:https://doi.org/10.15420/ecr.2017:23:11

Copyright Statement:

The copyright in this work belongs to Radcliffe Medical Media. Only articles clearly marked with the CC BY-NC logo are published with the Creative Commons by Attribution Licence. The CC BY-NC option was not available for Radcliffe journals before 1 January 2019. Articles marked ‘Open Access’ but not marked ‘CC BY-NC’ are made freely accessible at the time of publication but are subject to standard copyright law regarding reproduction and distribution. Permission is required for reuse of this content.

Topic: 2. Ischemic Heart Disease

 

Introduction and Objectives

Pharmacologic cardiac stress SPECT (PS-SPECT) is recommended for non-invasive evaluation of ischemic heart disease (IHD) in patients unable to exercise. Drugs used for stress in our centre are Dipyridamole (DIP) and Dobutamine (DBT). DIP can be associated to exercise (ex-DIP). The objective of the study is to evaluate the diagnostic capacity of the different strategies.

Materials and Methods

Retrospective study of 838 patients referred for PS-SPECT between 2010 and 2016.

Results

DIP was the main agent used for stress (730 tests), followed by DBT (63 tests) and combined ex-DIP (45 tests). DIP is preferred to DBT for its best security profile, reserving DBT to patients with contraindications for DIP administration. Basal characteristics of the patients were similar except for younger age in ex-DIP (69 vs 74 years- old) and lower proportion of women in the DBT group (36,5 % DBT vs 57,5 % DIP). Overall, they had high prevalence of cardiovascular risk factors and chronic IHD. Complications of the test were similar for DIP and DBT (19,8 % vs 18,6 %) and lower for ex-DIP (10,3 %). Hypotension was the main complication for DIP and arrhythmias and hypotension for DBT. Gammagraphic ischemia was detected in similar percentages with the different protocols (39 % with DIP, 44.4 % with ex-DIP and 44.9 % with DBT). However, number of invasive angiography was lower for DBT group (10.6 % vs 14.6 % DIP and 16.1 % ex-DIP) and revascularization higher for ex-DIP (10.3 %) compared to DIP and DBT groups (7.2 % and 6.7 %). Mortality after a mean follow-up of 20 months, was higher for DBT (24,5 %), followed by DIP (16,6 %) and ex-DIP (9,4 %).

Conclusions

PS-SPECT is currently reserved to older and sicker patients. Different protocols of study found similar rates of gammagraphic ischemia. Patients unable to exercise, especially those with contraindications for DIP administration, represent a high-risk profile of patients that are infrequently referred for invasive strategy independently of the result of the study and have high mortality risk. We should rethink about indication of this kind of tests in that kind of patients, tests that can be harmful, expensive and sometimes useless.

References

  1. Comparison of long-term mortality risk following normal exercise vs adenosine myocardial perfusion SPECT. Rozanski et al. Journal of Nuclear Cardiology 2010,17(6);999–1008.
    Crossref | PubMed
  2. Symptom-limited exercise combined with dipyridamole stress: Prognostic value in assessment of known or suspected coronary artery disease by use of gated SPECT imaging. Ahlberg A et al. Journal of Nuclear Cardiology 2008,15(1);42-56.
    Crossref | PubMed
  3. Survival by Stress Modality in Patients With a Normal Myocardial Perfusion Study. Johnson N et al. Am J Cardiol 2011;107:986 –989.
    Crossref | PubMed
Previous Volume Article Next Volume Article